Beyond the Breaking News

VA secretary fires back at critics of controversial COVID-19 treatment touted by Trump

United States News News

VA secretary fires back at critics of controversial COVID-19 treatment touted by Trump
United States Latest News,United States Headlines

Veterans Affairs Secretary Robert Wilkie fired back at critics of his agency's use of a controversial drug touted by Pres. Trump to treat COVID-19 patients in an interview with ABC News Chief Global Affairs Correspondent Martha Raddatz.

A cursory review of the drug's use at VA hospitals earlier this year found no positive effects on COVID-19 patients. Though the review indicated a possible connection between hydroxychloroquine and higher mortality rates, the paper was inconclusive and not a peer-reviewed scientific study.

Wilkie pointed to the lack of peer review and said the paper's calling the drug's efficacy and safety as a coronavirus treatment into question were not clinical studies. He added that hydroxychloroquine was prescribed by doctors in consultation with families, often for patients who were out of options. President Donald Trump listens as Secretary of Veterans Affairs Robert Wilkie speaks on protecting Americas seniors from the COVID-19 pandemic in the East Room of the White House, April 30, 2020. President Donald Trump listens as Secretary of Veterans Affairs Robert Wilkie speaks on protecting Americas seniors from the COVID-19 pandemic in the East Room of the White House, April 30, 2020."Many of those studies that you refer to don't look at the underlying medical conditions. In our VA, when we use this we use it with veterans who are -- in many cases -- in the last hours of life, but we also use them under FDA regimen." Tune into ABC at 1 p.m. ET and ABC News Live at 4 p.m. ET every weekday for special coverage of the novel coronavirus with the full ABC News team, including the latest news, context and analysis. The FDA has temporarily approved the use of hydroxychloroquine -- usually prescribed for malaria, lupus and certain types of arthritis -- allowing doctors to use the drug on some COVID-19 patients. The agency urges"close patient supervision" because side effects include deadly heart rhythm problems. Clinical trials of the drug's effectiveness as a coronavirus treatment are ongoing and remain inconclusive.

GooglePlease follow us on Google to support us
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

ABC /  🏆 471. in US

 

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Trump says he's finished hydroxychloroquine regimen to ward off COVID-19Trump says he's finished hydroxychloroquine regimen to ward off COVID-19The FDA has cautioned against the use of hydroxychloroquine and chloroquine for COVID-19 treatment outside of hospitals or clinical trials.
Read more »

Veterans Affairs Gives 1,300 Vets Unproven COVID-19 Drug Touted By TrumpVeterans Affairs Gives 1,300 Vets Unproven COVID-19 Drug Touted By TrumpHydroxychloroquine has not been shown to be effective against the coronavirus and may even lead to fatal side effects.
Read more »

Trump issues Brazil travel ban due to COVID-19Trump issues Brazil travel ban due to COVID-19FDA Commissioner Dr. Stephen Hahn warns 'the coronavirus is not yet contained' as states begin to open up: 'It is up to every individual to protect themselves and their community.'
Read more »

Twitter Users Mock Trump For Claiming He's Getting Great COVID-19 ReviewsTwitter Users Mock Trump For Claiming He's Getting Great COVID-19 ReviewsOne person joked that The New York Times gave the president's coronavirus response four stars, but 'Pandemic Weekly panned it.'
Read more »



Render Time: 2026-07-19 02:45:20